Skip to main content

Table 2 Baseline characteristics of study participants (n = 2,288), Boromo Health District, Burkina Faso (2004–2006)

From: A community effectiveness trial of strategies promoting intermittent preventive treatment with sulphadoxine-pyrimethamine in pregnant women in rural Burkina Faso

   Study arm
Characteristic All women
n = 2288
Intervention A
n = 743
Intervention B
n = 801
Control
n = 744
Age     
   Median (range), years 19 (14–41) 20 (14–41) 19 (15–37) 19 (15–35)
   ≤ 19 years 54.1 45.9 60.8 55.1
Gravidity     
   Primigravidae 55.6 57.1 56.2 53.6
Previous pregnancy outcome if secundigravid †:     
   Miscarriage or stillbirth 13.0 15.7 11.7 11.9
   Child death* 16.7 12.9 17.4 19.4
Formal education (any school)     
   Mother 21.5 25.3 18.1 21.4
   Father ‡ 26.6 29.1 28.0 22.6
Activity     
   Mother with own income 69.3 52.6 79.3 75.3
   Father farmer/breeder 92.9 87.9 94.8 93.5
Wealth Index* §     
   most poor 22.7 14.2 22.7 31.3
   poor 27.2 24.3 24.7 33.0
   less poor 24.9 19.6 32.7 22.1
   least poor 25.1 42.0 19.9 13.6
Marital status of mother     
   Not married 5.1 6.1 4.4 4.8
Religion     
   Muslim 48.0 57.5 44.9 41.8
   Christian 19.1 22.3 16.5 18.8
   Traditional 32.9 20.2 38.6 39.4
Ethnic group*     
   Bwaba/Dafing 53.9 12.9 69.2 78.5
   Ko/Nounouma 24.1 60.8 10.7 1.9
   Mossi 11.3 16.3 11.1 6.6
   Fulani 5.5 5.2 7.1 4.0
   Other 5.1 4.7 1.9 9.0
Distance from nearest HC (km)     
   ≤ 5 73.0 76.9 61.3 81.7
   > 5 27.0 23.2 28.7 18.3
Bed net*     
   Owns bed net at enrolment 30.2 35.1 35.8 19.1
  1. Intervention A = IPTp+promotion; Intervention B = IPTp alone; Control = CQ chemoprophylaxis; HC = health centre
  2. Numbers are proportions if not otherwise stated.
  3. * Proportions significantly different between study arms
  4. † Intervention A n = 319; Intervention B n = 351; Control n = 345
  5. ‡ Intervention A n = 690; Intervention B n = 768; Control n = 721
  6. §Intervention A n = 741; Intervention B n = 787; Control n = 737